Related Experiment Video
Updated: Sep 14, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Epidemiology and clinical characteristics of human metapneumovirus]
Zsófia Gáspár1,2, Bálint Tresó3, Laura Kocsis3
11 Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet, Infektológiai Osztály Budapest, Albert Flórián út 5-7., 1097 Magyarország.
Abstract:
Introduction: Human metapneumovirus (hMPV) is a respiratory pathogen that can cause severe complications, particularly in patients with certain comorbidities. Its significance has grown due to insights from the COVID–19 pandemic and the rising hMPV cases reported by the Chinese Centre for Disease Control and Prevention in late 2024. Objective: The aim of the study was to retrospectively analyze the epidemiological and clinical characteristics of hMPV cases diagnosed between 2019 and 2024 at the Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases. Method: A single-center, retrospective cohort study was conducted between December 2019 and December 2024, including all adult patients who had confirmed hMPV infection by real-time polymerase chain reaction (RT-PCR). Clinical data (demographics, comorbidities, initial clinical presentation, viral co-infection) and complications (hospitalization, oxygen requirement, pneumonitis, intensive care unit admission, mechanical ventilation, in-hospital mortality) were recorded. The primary composite endpoint, which also determined the complicated course, was based on in-hospital mortality, intensive care unit admission, or mechanical ventilation initiation. Results: A total of 80 patients were included (mean age: 58 ± 30 years; male: n = 47, 58.8%). A complicated course was observed in 10% (n = 8), which occurred significantly more frequently in older patients (66 ± 10 vs. 55±31 years, p = 0.05). Pneumonitis occurred in 45% (n = 36), hospitalization in 42.5% (n = 34), oxygen requirement in 30% (n = 24), intensive care unit admission in 8.75% (n =7), mechanical ventilation in 6.25% (n = 5), and in-hospital mortality in 6.25% (n = 5). Intensive care unit admission and in-hospital mortality were not always exclusively due to hMPV infection. Discussion: According to our findings, the clinical significance of hMPV is important in immunocompromised, elderly, and patients with chronic respiratory diseases, as the infection can lead to severe respiratory complications. Conclusion: In summary, when hMPV infection is suspected, diagnostics should be extended including hMPV, particularly in high-risk groups, as early diagnosis is crucial for preventing severe outcomes. Orv Hetil. 2025; 166(29): 1132–1138.
Insights
Human metapneumovirus (hMPV) infections can lead to severe respiratory complications, particularly in older adults and those with underlying conditions. Early hMPV diagnostics are crucial for high-risk groups to prevent severe outcomes.
Area of Science:
- Virology
- Infectious Diseases
- Epidemiology
Background:
- Human metapneumovirus (hMPV) is an emerging respiratory pathogen with increasing recognition, highlighted by recent case reports and the COVID-19 pandemic.
- hMPV can cause severe respiratory illness, especially in vulnerable populations, necessitating a better understanding of its clinical impact.
Purpose of the Study:
- To retrospectively analyze the epidemiological and clinical characteristics of hMPV infections in adult patients.
- To identify risk factors and complications associated with hMPV infection.
Main Methods:
- A single-center, retrospective cohort study included 80 adult patients with confirmed hMPV infection via RT-PCR between December 2019 and December 2024.
- Data collected included demographics, comorbidities, clinical presentation, viral co-infections, and complications such as hospitalization, oxygen requirement, pneumonitis, ICU admission, mechanical ventilation, and mortality.
Main Results:
- A complicated course was observed in 10% of patients, significantly more frequent in older individuals (p=0.05).
- Pneumonitis occurred in 45% of cases, with 42.5% requiring hospitalization and 30% needing oxygen. ICU admission and mechanical ventilation were required in 8.75% and 6.25% of cases, respectively. In-hospital mortality was 6.25%.
Conclusions:
- hMPV infection poses a significant clinical threat, particularly to immunocompromised individuals, the elderly, and those with chronic respiratory diseases.
- Expanding diagnostic testing to include hMPV is vital for early detection and management, especially in high-risk populations, to mitigate severe outcomes.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: